167 related articles for article (PubMed ID: 37149836)
21. Differentiated thyroid cancer and selenium supplements for protection of salivary glands from
Mazokopakis E
Hell J Nucl Med; 2018; 21(1):83-84. PubMed ID: 29550852
[TBL] [Abstract][Full Text] [Related]
22. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.
Almeida JP; Sanabria AE; Lima EN; Kowalski LP
Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917
[TBL] [Abstract][Full Text] [Related]
23. Assessment of salivary gland dysfunction after radioiodine therapy for thyroid carcinoma using non-contrast-enhanced CT: the significance of changes in volume and attenuation of the glands.
Nabaa B; Takahashi K; Sasaki T; Okizaki A; Aburano T
AJNR Am J Neuroradiol; 2012 Nov; 33(10):1964-70. PubMed ID: 22555571
[TBL] [Abstract][Full Text] [Related]
24. Effect of vitamin E and supragingival scaling on salivary gland function in patients with differentiated thyroid cancer treated with 131I.
Cheng Y; Tong H; Li X; Zhang X; Fang J; Yue R; Huang N; Tian J; Yu F; Gao Y
Nucl Med Commun; 2022 Sep; 43(9):995-1003. PubMed ID: 35950355
[TBL] [Abstract][Full Text] [Related]
25. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?
Fallahi B; Beiki D; Abedi SM; Saghari M; Fard-Esfahani A; Akhzari F; Mokarami B; Eftekhari M
Nucl Med Commun; 2013 Aug; 34(8):777-86. PubMed ID: 23708871
[TBL] [Abstract][Full Text] [Related]
26. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
[TBL] [Abstract][Full Text] [Related]
27. Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.
Kim YM; Choi JS; Hong SB; Hyun IY; Lim JY
Head Neck; 2016 Jan; 38(1):51-8. PubMed ID: 24995941
[TBL] [Abstract][Full Text] [Related]
28. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
Macioszek A; Baczyk M; Kopeć T; Sowiński J
Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
[TBL] [Abstract][Full Text] [Related]
29. Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated With Radioactive Iodine Therapy.
Bojarsky M; Baran JA; Halada S; Isaza A; Zhuang H; States L; Grant FD; Robbins S; Sisko L; Ricarte-Filho JC; Kazahaya K; Adzick NS; Mostoufi-Moab S; Bauer AJ
J Clin Endocrinol Metab; 2023 Nov; 108(12):3338-3344. PubMed ID: 37265226
[TBL] [Abstract][Full Text] [Related]
30. Effects of Radioiodine Treatment on Salivary Gland Function in Patients with Differentiated Thyroid Carcinoma: A Prospective Study.
Klein Hesselink EN; Brouwers AH; de Jong JR; van der Horst-Schrivers AN; Coppes RP; Lefrandt JD; Jager PL; Vissink A; Links TP
J Nucl Med; 2016 Nov; 57(11):1685-1691. PubMed ID: 27339871
[TBL] [Abstract][Full Text] [Related]
31. Assessment of Salivary Gland Function Using Salivary Scintigraphy in Pre and Post Radioactive Iodine Therapy in Diagnosed Thyroid Carcinoma Patients.
Badam RK; Suram J; Babu DB; Waghray S; Marshal R; Bontha SC; Lavanya R; Kanth S
J Clin Diagn Res; 2016 Jan; 10(1):ZC60-2. PubMed ID: 26894178
[TBL] [Abstract][Full Text] [Related]
32. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
[TBL] [Abstract][Full Text] [Related]
33. Salivary gland dysfunction after radioactive iodine (I-131) therapy in patients following total thyroidectomy: emphasis on radioactive iodine therapy dose.
Lee HN; An JY; Lee KM; Kim EJ; Choi WS; Kim DY
Clin Imaging; 2015; 39(3):396-400. PubMed ID: 25630229
[TBL] [Abstract][Full Text] [Related]
34. Combination of Stimulated Thyroglobulin and Antithyroglobulin Antibody Predicts the Efficacy and Prognosis of
Pan M; Li Z; Jia M; Lu X
Front Endocrinol (Lausanne); 2022; 13():857057. PubMed ID: 35464061
[TBL] [Abstract][Full Text] [Related]
35. Sialadenitis after radioiodine therapy. Analysis of factors that influence the response to medical treatment.
Geres AE; Mereshian PS; Fernández S; Rey Caro DG; Castro R; Podio R; Ojeda S
Endocrinol Nutr; 2015 Dec; 62(10):493-8. PubMed ID: 26459118
[TBL] [Abstract][Full Text] [Related]
36. Modulation of sodium/iodide symporter expression in the salivary gland.
La Perle KM; Kim DC; Hall NC; Bobbey A; Shen DH; Nagy RS; Wakely PE; Lehman A; Jarjoura D; Jhiang SM
Thyroid; 2013 Aug; 23(8):1029-36. PubMed ID: 23441638
[TBL] [Abstract][Full Text] [Related]
37. Radioactive iodine: An unappreciated threat to salivary gland function.
Sunavala-Dossabhoy G
Oral Dis; 2018 Mar; 24(1-2):198-201. PubMed ID: 29480611
[TBL] [Abstract][Full Text] [Related]
38. Salivary glands ultrasound examination after radioiodine-131 treatment for differentiated thyroid cancer.
Brozzi F; Rago T; Bencivelli W; Bianchi F; Santini P; Vitti P; Pinchera A; Ceccarelli C
J Endocrinol Invest; 2013 Mar; 36(3):153-6. PubMed ID: 22522602
[TBL] [Abstract][Full Text] [Related]
39. Limited cytoprotective effects of amifostine in high-dose radioactive iodine 131-treated well-differentiated thyroid cancer patients: analysis of quantitative salivary scan.
Kim SJ; Choi HY; Kim IJ; Kim YK; Jun S; Nam HY; Kim JS
Thyroid; 2008 Mar; 18(3):325-31. PubMed ID: 18341378
[TBL] [Abstract][Full Text] [Related]
40. The influence of saliva flow stimulation on the absorbed radiation dose to the salivary glands during radioiodine therapy of thyroid cancer using 124I PET(/CT) imaging.
Jentzen W; Balschuweit D; Schmitz J; Freudenberg L; Eising E; Hilbel T; Bockisch A; Stahl A
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2298-306. PubMed ID: 20625723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]